Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ravenquest Biomed Inc RVVQF

Ravenquest BioMed Inc is a Canada-based diversified cannabis company with divisions focused upon cannabis production, management services and consulting and specialized research and development. It provides integrated solutions to companies in the cannabis industry and provides growing and drying technologies, patient and genetic management systems, and security management solutions The company operates through the following segments - Consulting business and Cultivation and Sale of Medical Cannabis.


GREY:RVVQF - Post by User

Bullboard Posts
Comment by cornwallison Oct 17, 2018 11:49am
81 Views
Post# 28819360

RE:RE:RE:Update License

RE:RE:RE:Update License
Once the licenses have been acquired, I would like to see Mr. Robinson, or Ms. Sable, or whoever else was heavily involved with the licensing process give us a detailed explanation about the licensing delays.
 
Of course, delays are an expected part of doing business, especially when regulators are involved.
 
But in this case the gap between the earlier optimism (like "Expecting license to sell mid-2018, right in time for adult recreational legalization across Canada!" in April, and "August 2018 we anticipate LP in Edmonton and license to sell and dispense in Markham." in July) and the actual outcome is bigger than I was thinking it would be.
 
I'd like to know things like:
* What originally caused management to think that licensing by "mid-2018"/"August 2018" was feasible?
* Did the regulators require more information, and if so, why wasn't this information provided initially?
* Were there any failed or unsuccessful inspections? If so, what were the reasons?
* Were unanticipated changes to operating procedures, the facilities, the equipment, the plants, ..., required?
* Did the use of the orbital gardens complicate the licensing process at all?
* Did management underestimate the time required by the regulators?
* Does Mr. Robinson's cryptic "Many people will have a big wake up call coming." tweet from September apply at all to RQB's licensing experience, and if it does, how so?
 
In my opinion, management sharing a thorough retrospective analysis of the licensing delays may help regain some of the trust that I think has been lost recently.
Bullboard Posts